UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 71

Sortiert nach

The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal function

Annals of oncology, 2012-03, Vol.23 (3), p.722-729

2012

Volltextzugriff (PDF)

Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG)

Annals of oncology, 2008-04, Vol.19 (4), p.780-786

2008

Volltextzugriff (PDF)

Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma

Blood cancer journal (New York), 2016-11, Vol.6 (11), p.e500-e500

2016

Volltextzugriff (PDF)

283 AZACYTIDINE UPREGULATES PERFORIN EXPRESSION IN CYTOTOXIC T AND NATURAL KILLER CELLS OF RESPONDING PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)

Leukemia research, 2015-04, Vol.39, p.S141-S141

2015

Volltextzugriff (PDF)

P-244 Distinct epigenetic modulation of signal transducer and activator of transcription (STAT) signaling in FOXP3+ T regulatory cells of CMML-2 patients

Leukemia research, 2013-05, Vol.37, p.S133-S133

2013

Volltextzugriff (PDF)

Paroxysmal nocturnal haemoglobinuria, lupus and pregnancy

Journal of obstetrics and gynaecology, 2013-07, Vol.33 (5), p.523-523

2013

Volltextzugriff (PDF)

Global Impairment of CD4+CD25+FOXP3+ Regulatory T Cells in Idiopathic Pulmonary Fibrosis

American journal of respiratory and critical care medicine, 2009-06, Vol.179 (12), p.1121-1130

2009

Volltextzugriff (PDF)

Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone

Seminars in oncology, 2003-04, Vol.30 (2), p.265-269

2003

Volltextzugriff (PDF)

Effect of HbS in the determination of HbA2 with the Menarini HA-8160 analyzer and comparison with other instruments

International journal of laboratory hematology, 2009-12, Vol.31 (6), p.665-672

2009

Volltextzugriff (PDF)

Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy

Haematologica (Roma), 2015-11, Vol.100 (11), p.e446

2015

Volltextzugriff (PDF)

Proteolytic matrix metallopeptidases and inhibitors in BCR-ABL1-negative myeloproliferative neoplasms: correlation with JAK2 mutation status

Acta haematologica, 2011-01, Vol.126 (1), p.54-62

2011

Volltextzugriff (PDF)

319 Response to treatment with erythropoietin in patients with MDS highly predicts low risk of evolution to AML and longer survival

Leukemia research, 2011, Vol.35, p.S127-S128

2011

Volltextzugriff (PDF)

311 STAT signaling alterations in leukemic progenitors can predict the response of myelodysplastic syndrome (MDS) patients to azacytidine

Leukemia research, 2011, Vol.35, p.S123-S124

2011

Volltextzugriff (PDF)

Hydroxyurea and Anagrelide Combination Therapy in Patients with Chronic Myeloproliferative Diseases Resistant or Intolerant to Monotherapy

Acta haematologica, 2008-01, Vol.120 (4), p.195-198

2008

Volltextzugriff (PDF)

CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group

The cancer journal (Sudbury, Mass.), 2007-09, Vol.13 (5), p.327

2007

Volltextzugriff (PDF)

Long-term bone marrow cultures (LTBMC) from essential thrombocythemia (ET) patients with or without JAK2617V>F mutation

Leukemia research, 2008-10, Vol.32 (10), p.1593-1596

2008

Volltextzugriff (PDF)

Successful treatment of lymph node extramedullary plasmacytoma with bortezomib

Annals of hematology, 2006-03, Vol.85 (3), p.188-190

2006

Volltextzugriff (PDF)

Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases

Acta haematologica, 2005, Vol.113 (2), p.97-103

2005

Volltextzugriff (PDF)

P050 Evidence for a role of CD4+CD25high Foxp3+ regulatory T-cells in the pathogenesis of myelodysplastic syndromes (MDS)

Leukemia research, 2007, Vol.31, p.S67-S68

2007

Volltextzugriff (PDF)

PSY12 - Safety And Tolerability Of Azacitidine In Patients With Intermidiate-2 And High Risk Myelodysplastic Syndromes In GreeceA Retrospective Chart Review Study For The Daily Practise

Value in health, 2014-05, Vol.17 (3), p.A225-A225

2014

Volltextzugriff (PDF)

Safety And Tolerability Of Azacitidine In Patients With Intermidiate-2 And High Risk Myelodysplastic Syndromes In GreeceA Retrospective Chart Review Study For The Daily Practise

Value in health, 2014-05, Vol.17 (3), p.A225-A225

2014

Volltextzugriff (PDF)

Extramedullary plasmacytoma: report of two cases with uncommon presentation

Annals of hematology, 2005-03, Vol.84 (3), p.188-191

2005

Volltextzugriff (PDF)

Treatment of red cell aplasia in CLL with fludarabine

Leukemia, 1999-11, Vol.13 (11), p.1897-1897

1999

Volltextzugriff (PDF)

Simultaneous occurrence of multiple myeloma and Hodgkin's disease. A case report

Haematologica (Roma), 2000-07, Vol.85 (7), p.772

2000

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(71)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Humans
(44)
Life Sciences & Biomedicine
(43)
Female
(31)
Male
(29)
Middle Aged
(29)
Hematology
(25)
Adult
(24)
Aged
(22)
Biological And Medical Sciences
(16)
Medical Sciences
(15)
Oncology
(15)
Aged, 80 And Over
(13)
Adolescent
(8)
Chemotherapy
(8)
Hematologic And Hematopoietic Diseases
(7)
Pharmacology. Drug Treatments
(7)
Antineoplastic Agents
(6)
Hematology, Oncology And Palliative Medicine
(6)
Remission Induction
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Acta Haematologica
(10)
Leukemia Research
(9)
Haematologica
(5)
Leukemia
(5)
Annals Of Oncology
(3)
European Journal Of Haematology
(3)
Annals Of Hematology
(2)
Blood
(2)
International Journal Of Laboratory Hematology
(2)
Value In Health
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal function

Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG)

Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma

283 AZACYTIDINE UPREGULATES PERFORIN EXPRESSION IN CYTOTOXIC T AND NATURAL KILLER CELLS OF RESPONDING PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)

P-244 Distinct epigenetic modulation of signal transducer and activator of transcription (STAT) signaling in FOXP3+ T regulatory cells of CMML-2 patients

Paroxysmal nocturnal haemoglobinuria, lupus and pregnancy

Global Impairment of CD4+CD25+FOXP3+ Regulatory T Cells in Idiopathic Pulmonary Fibrosis

Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone

Effect of HbS in the determination of HbA2 with the Menarini HA-8160 analyzer and comparison with other instruments

Competing risk survival analysis in patients with symptomatic Waldenström macroglobulinemia: the impact of disease unrelated mortality and of rituximab-based primary therapy

Proteolytic matrix metallopeptidases and inhibitors in BCR-ABL1-negative myeloproliferative neoplasms: correlation with JAK2 mutation status

319 Response to treatment with erythropoietin in patients with MDS highly predicts low risk of evolution to AML and longer survival

311 STAT signaling alterations in leukemic progenitors can predict the response of myelodysplastic syndrome (MDS) patients to azacytidine

Hydroxyurea and Anagrelide Combination Therapy in Patients with Chronic Myeloproliferative Diseases Resistant or Intolerant to Monotherapy

CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group

Long-term bone marrow cultures (LTBMC) from essential thrombocythemia (ET) patients with or without JAK2617V>F mutation

PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy

Successful treatment of lymph node extramedullary plasmacytoma with bortezomib

Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases

P050 Evidence for a role of CD4+CD25high Foxp3+ regulatory T-cells in the pathogenesis of myelodysplastic syndromes (MDS)

PSY12 - Safety And Tolerability Of Azacitidine In Patients With Intermidiate-2 And High Risk Myelodysplastic Syndromes In GreeceA Retrospective Chart Review Study For The Daily Practise

Safety And Tolerability Of Azacitidine In Patients With Intermidiate-2 And High Risk Myelodysplastic Syndromes In GreeceA Retrospective Chart Review Study For The Daily Practise

Extramedullary plasmacytoma: report of two cases with uncommon presentation

Treatment of red cell aplasia in CLL with fludarabine

Simultaneous occurrence of multiple myeloma and Hodgkin's disease. A case report

Suchergebnisse filtern